A detailed history of Swiss National Bank transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 193,800 shares of VKTX stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
193,800
Previous 193,600 0.1%
Holding current value
$10.2 Million
Previous $10.3 Million 19.56%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$49.84 - $70.47 $9,968 - $14,094
200 Added 0.1%
193,800 $12.3 Million
Q2 2024

Aug 08, 2024

BUY
$47.39 - $80.2 $1.18 Million - $2.01 Million
25,000 Added 14.83%
193,600 $10.3 Million
Q1 2024

May 07, 2024

BUY
$17.4 - $94.5 $17,400 - $94,500
1,000 Added 0.6%
168,600 $13.8 Million
Q4 2023

Feb 06, 2024

SELL
$9.24 - $19.64 $276,276 - $587,236
-29,900 Reduced 15.14%
167,600 $3.12 Million
Q3 2023

Nov 08, 2023

SELL
$10.92 - $16.0 $92,820 - $136,000
-8,500 Reduced 4.13%
197,500 $2.19 Million
Q2 2023

Aug 09, 2023

BUY
$14.84 - $24.79 $580,244 - $969,289
39,100 Added 23.43%
206,000 $3.34 Million
Q1 2023

May 10, 2023

BUY
$8.08 - $17.33 $1.35 Million - $2.89 Million
166,900 New
166,900 $2.78 Million
Q2 2022

Aug 09, 2022

SELL
$2.11 - $3.15 $351,315 - $524,475
-166,500 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$3.0 - $4.88 $33,600 - $54,656
11,200 Added 7.21%
166,500 $500,000
Q3 2021

Nov 08, 2021

BUY
$5.58 - $7.04 $56,358 - $71,104
10,100 Added 6.96%
155,300 $975,000
Q2 2021

Aug 06, 2021

SELL
$5.19 - $6.73 $24,912 - $32,304
-4,800 Reduced 3.2%
145,200 $870,000
Q1 2021

May 07, 2021

BUY
$5.74 - $9.67 $17,220 - $29,010
3,000 Added 2.04%
150,000 $949,000
Q2 2020

Aug 05, 2020

BUY
$4.35 - $8.08 $98,309 - $182,608
22,600 Added 18.17%
147,000 $1.06 Million
Q4 2019

Feb 06, 2020

BUY
$6.38 - $8.73 $30,624 - $41,904
4,800 Added 4.01%
124,400 $998,000
Q2 2019

Aug 02, 2019

BUY
$7.67 - $10.63 $18,408 - $25,512
2,400 Added 2.05%
119,600 $993,000
Q1 2019

May 10, 2019

BUY
$7.58 - $9.94 $42,448 - $55,664
5,600 Added 5.02%
117,200 $1.17 Million
Q4 2018

Feb 13, 2019

BUY
$7.16 - $16.21 $799,056 - $1.81 Million
111,600 New
111,600 $854,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.